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Abstract 34 
A novel lanC-like sequence was identified from the dominant human gut bacterium Blautia obeum strain A2-35 
162. This sequence was extended to reveal putative biosynthetic and transport genes, two sets of regulatory 36 
genes, immunity genes, three copies of a nisin–like lanA gene (nsoA1, 2, 3) with an unusual leader peptide and 37 
a fourth putative lanA gene (nsoA4). Comparison with other nisin clusters showed the closest relationship to 38 
nisin U.  39 
B. obeum A2-162 demonstrated antimicrobial activity against Clostridium perfringens when grown on solid 40 
media in the presence of trypsin. Fusions of the predicted nsoA structural sequences with the nisin A leader 41 
were expressed in Lactococcus lactis containing the nisin A cluster without nisA. Expression of the nisA leader 42 
sequence fused to the predicted structural nsoA1 produced a growth defect in L. lactis which was dependent 43 
upon the presence of biosynthetic genes, but failed to produce antimicrobial activity. Insertion of the nso cluster 44 
into L. lactis MG1614 gave an increased immunity to nisin A but this was not replicated by the expression of 45 
nsoI.  46 
Nisin A induction of L. lactis containing the nso cluster and nisRK genes allowed detection of the NsoA1 pre-47 
peptide by Western hybridisation. When this heterologous producer was grown with nisin induction on solid 48 
media, antimicrobial activity was demonstrated in the presence of trypsin against C. perfringens, Clostridium 49 
difficile and L. lactis. This research adds to evidence that lantibiotic production may be an important trait of 50 
gut bacteria and could lead to the development of novel treatments for intestinal diseases. 51 
 52 
INTRODUCTION 53 
Lantibiotics are small amphiphilic lanthipeptides produced by Gram-positive bacteria and commonly have 54 
antimicrobial activity against a wide range of mostly Gram-positive bacteria (Arnison et al., 2013; Cotter et 55 
al., 2013). While their potential in applications has so far mostly been seen as preservatives or as probiotics 56 
(Hegarty et al., 2016), they have been of increasing interest since novel therapeutic applications have been 57 
discovered (Dischinger et al., 2014; Hammami et al., 2012; Malik et al., 2012). Lantibiotics are gene 58 
encoded and the genes involved in their biosynthesis, regulation and immunity are usually clustered. 59 
Following synthesis of the precursor peptides on the ribosome, they undergo a series of post-translational 60 
modifications such as serine and threonine dehydration and lanthionine bridge formation to produce the 61 
characteristic lanthionine and methyllanthionine rings which contribute to their stability (Chatterjee et al., 62 
2005). Their mode of synthesis makes genetic engineering a powerful tool to create improved peptides and to 63 
study biosynthesis (Field et al., 2012; Montalban-Lopez et al., 2017). 64 
Nisin A is the best characterized example of the type A lantibiotics; it is the only bacteriocin to date to be 65 
authorized for use as a food preservative, under the name Nisaplin, and is also in use for prevention of 66 
bovine mastitis (Dischinger et al., 2014). It is a highly stable peptide with antimicrobial activity against a 67 
wide range of Gram-positive organisms including food spoilage and food pathogenic bacteria from genera 68 
such as Clostridium, Listeria, Staphylococcus and Bacillus (Shin et al., 2016). The nisin A biosynthetic 69 
cluster is located within a 70 kb transposon named Tn5307 which has been shown to be transferrable by 70 
conjugation (Horn et al., 1991). To date, eight natural forms of nisin have been identified from either 71 
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lactococci (A, Z, F, Q) or streptococci (U, U2, P, H), with nisin H representing the first example from a 72 
gastrointestinal tract bacterium (O'Connor et al., 2015). A related nisin homologue has also been identified in 73 
the thermophilic bacterium Geobacillus thermodenitrificans (Garg et al., 2012). Beside the natural forms of 74 
nisin, both random and targeted mutation studies have created libraries of nisin derivatives, the most notable 75 
being a nisin A derivative with an S29G substitution, with enhanced antimicrobial activity against both 76 
Gram-positive and Gram negative pathogens (Field et al., 2012). Hinge region variants such as N20P, M21V 77 
(Field et al., 2008), K22T (Field et al., 2010) and N20K, M21K (Yuan et al., 2004) have also led to increases 78 
in bioactivity against a range of bacteria.  79 
In addition to the pre-peptide gene nisA, nisin gene clusters typically encode NisB, an enzyme which 80 
dehydrates serines and threonines and NisC, a zinc-dependent metalloprotein which cyclises dehydrated 81 
residues to cysteines, both of which have been shown to be essential for nisin production (Ra et al., 1999). In 82 
order for these biosynthetic modifications to take place, it is important that the appropriate leader peptide is 83 
attached to the bacteriocin precursor. In the case of nisin A, the leader peptide is removed by the protease 84 
NisP following transport across the cell membrane by NisT, an ABC-transporter which forms a membrane-85 
associated complex with NisB and NisC. Once modified, the mature nisins all contain three dehydrated 86 
amino acids and five thioether bridges. NisFEG and NisI control self-immunity, while the two component 87 
sensor-histidine kinase system NisRK allows self-induction of the nisA promoter by the mature nisin product 88 
(Chatterjee et al., 2005). The modified nisin A and U molecules have been shown to have the capacity to act 89 
as inducers of their own and each other's promoters even when attached to their leader peptides (Wirawan et 90 
al., 2006), while cross-immunity has also been demonstrated between nisins A and Z (de Vos et al., 1993) 91 
and A and H (O'Connor et al., 2015). 92 
Heterologous expression of lantibiotic clusters and genes, especially when their inducing conditions are not 93 
known, has been a powerful aid in the sequencing and characterization of several lantibiotic clusters such as 94 
those of epicidin 280 (Heidrich et al., 1998), enterocin A (O'Keeffe et al., 1999) and nukacin ISK-1 (Aso et 95 
al., 2004). The nisin A biosynthetic cluster has already been expressed successfully in L. lactis and 96 
Enterococcus sp (Li and O'Sullivan, 2002); furthermore, the nisin biosynthetic machinery has been shown to 97 
be capable of modifying other non-nisin peptides (Rink et al., 2005), while the nisin promoter elements have 98 
been used extensively for inducible expression of cloned genes (Mierau and Kleerebezem, 2005). The 99 
extreme robustness of the biosynthetic machinery was demonstrated by Majchrzykiewicz et al. 100 
(Majchrzykiewicz et al., 2010), who successfully expressed a fully modified and biologically active two-101 
component class II lantibiotic from Streptococcus pneumoniae using the nisin A biosynthetic machinery, 102 
while several other studies have demonstrated that the lantibiotic biosynthetic machinery is able to recognize 103 
alternative peptides containing the peptide leader sequence of their own lanA gene and in some cases modify 104 
them (Kluskens et al., 2005; Rink et al., 2007). 105 
The human gut harbours a large number of bacteria, reaching 1012 bacteria per gram of intestinal content, 106 
that are diverse in their composition and contain many unknown species; other species, such as Blautia 107 
obeum, are recognized as being dominant in the human colon (Flint et al., 2012). It is a rich potential source 108 
of novel antimicrobials which have evolved to function in the challenging conditions of the gastrointestinal 109 
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tract, and recent research suggests bacteriocin production is widespread (Birri et al., 2013; Walsh et al., 110 
2015). Using genome mining of human gut bacteria, new lantibiotic sequences sharing considerable 111 
sequence homology with the Class AI lantibiotics and especially nisin U were discovered from anaerobic 112 
bacterium Blautia obeum A2-162. The novel lantibiotic cluster was cloned into L. lactis and evidence of 113 
antimicrobial activity and cross-immunity with nisin A was shown. 114 
 115 
METHODS 116 
Strains, plasmids and growth conditions.  Lactococcus lactis strains and plasmids used in this study are 117 
listed in Table 1 and primers in Table S1. Ruminococcus obeum A2-162 was isolated previously from human 118 
faeces from an adult female consuming a Western style diet (Barcenilla, 1999; Dabek et al., 2008; Flint et 119 
al., 2007) and its genome was sequenced as part of the MetaHIT project. R. obeum has subsequently been re-120 
classified as Blautia obeum (Lawson and Finegold, 2015). B. obeum, C. perfringens NCTC 3110 and C. 121 
difficile NCTC 11204 were cultured in pre-reduced brain heart infusion broth (BHI, Oxoid) with 122 
complements (50 mg/l vitamin K, 5 mg/l hemin, 1 mg/l resazurin, 0.5 g/l L-cysteine) at 37˚C in an 123 
atmosphere of 5% CO2, 10% H2 in N2; L. lactis strains were cultured in M17 medium (Oxoid) supplemented 124 
with 5 g/l glucose (GM17) at 30˚C; E. coli MC1022 was cultured in L media (Oxoid) at 37˚C with shaking. 125 
For plasmid selection erythromycin and chloramphenicol were used at 5 μg/ml for L. lactis or at 100 μg/ml 126 
and 15 μg/ml respectively for E. coli and ampicillin was used at 100 μg/ml.  127 
 128 
Degenerate Oligonucleotide Primer design and screening for lanC genes.  Genomic DNA from B. obeum 129 
A2-162 was extracted using the Qiagen Genomic-tip kit. Degenerate AT-rich primers lanC340 and rlanC460 130 
were designed from the WCYG region (position 294 in SpaC) and the GLIxG region (position 403 in SpaC) 131 
of an alignment of the following LanC sequences from the NCBI database: CAA74351 (EciC), AAF99580 132 
(Mut C), CAA48383 (NisC), CAA90026 (PepC) P33115 (SpaC), BAB08164 (SrtC) P30196 (EpiC), as 133 
described previously (Mayer et al., 2006). Degenerate oligonucleotide primer PCR used GoTaq (Promega) 134 
with 10 μM of each degenerate primer lanC340 and rlanC460. PCR products were electrophoresed, bands of 135 
200-300 bp were excised and extracted from agarose gels (Qiaex II Gel extraction kit, Qiagen), purified 136 
using Sureclean (Bioline), ligated into vector pCR2.1 and transformed into chemically competent E. coli 137 
TOP10 (TA Cloning Kit, Life Technologies). Positive colonies were identified by colony PCR using GoTaq 138 
with universal and reverse primers and confirmed by sequencing. Sequence was extended using the DNA 139 
Walking SpeedUpTM Premix kit (Seegene) and genomic DNA.  140 
 141 
DNA library construction and lantibiotic cluster sequencing.  Genomic DNA from B. obeum A2-162 was 142 
used to construct a DNA library (Lucigen Corp, Middleton, WI, USA) using the E. coli vector pJAZZ-OC. 143 
For hybridisation analysis of the library, a 736 bp DNA probe comprising bases 15292 to 16027 of the 144 
lantibiotic cluster sequence (accession number KY914474), which includes the C-terminus of the nsoC gene 145 
and downstream sequence, was prepared by PCR using primers 5PrA2162280 and 3PrA2162c and purified. 146 
Hybridisation of the probe to filter membranes arrayed with the library was performed by pretreating the 147 
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membranes for 2 h with gentle shaking in 5 x SSC (saline sodium citrate buffer (Sambrook et al., 1989)), 148 
0.5% SDS, 1 mM EDTA (pH 8.0) at 42C, scraping with wet paper towels and rinsing in 2 x SSC then 149 
hybridisation using the ECL hybridisation kit (GE Healthcare). Positive clones identified from the DNA 150 
library were cultured and sequenced using primers pJAZZf and nzrevcpJAZZ. The known sequence was 151 
extended from the library clones using primer walking and the gaps were filled by PCR until the lantibiotic 152 
cluster had been fully sequenced in both directions.  153 
 154 
Bioinformatic analysis.  Genomic DNA sequences were assembled with the Phred-Phrap program and 155 
contigs were assembled in SeqMan (DNASTAR). ORFs were determined by Artemis (Rutherford, 2000). 156 
Start sites were selected on best match to the consensus ribosome binding site AGGAGG where present and 157 
to homologous sequences identified using BLASTp and tBLASTx searches (Altschul et al., 1997) using the 158 
UniProtKB/TrEMBL database. Amino acid alignments were performed using the Clustal W algorithm in 159 
Vector NTI (Invitrogen) and edited in Genedoc; the average distance tree was generated using BLOSUM62 160 
from the Clustal WS alignment of secondary structure prediction of the peptide sequences (Larkin et al., 161 
2007). Pairwise cluster comparisons were performed using BLASTn and tBLASTx from BLASTall vs 162 
2.2.26. The clusters were aligned using mega-cc 7 with the Neighbor Joining method (MUSCLE) and a tree 163 
was made using RAxML vs 8.2.9 with the BS and ML recommended settings. Cluster comparisons were 164 
visualized using the tBLASTx comparison files and RAxML tree in R vs 3.3.2 using the genoPlotR package. 165 
 166 
Expression of the Nisin O cluster in L. lactis.  A 17,438 bp sequence containing the novel lantibiotic 167 
cluster was restricted from the identified pJAZZ-OC clone with ClaI and PstI (NEB) then ligated into vector 168 
pIL253 (MspI, PstI restricted and dephosphorylated (Antarctic Phosphatase, NEB)) using Fastlink DNA 169 
ligase (Epicentre) to create pnso. The construct was transformed into electrocompetent L. lactis MG1614 170 
using a Gene Pulse Xcell (BioRad, (Mayer et al., 2008)). Plasmid DNA was extracted using the QIAprep 171 
Spin Miniprep Kit (Qiagen) with an additional 15 min at 37˚C with 5 mg/ml lysozyme and 30 U mutanolysin 172 
(Sigma) at the lysis stage and the insert was confirmed by sequencing with primers pIL253F and pIL253R. 173 
The region containing the four nsoA genes was deleted from pnso by splice overlap extension PCR (Horton 174 
et al., 1989) using Phusion (Finnzymes). Sequences surrounding the nsoA region were amplified at the 5’ 175 
end using primers splA1 and splA2 and at the 3’ end with primers splA3 and splA4. These products were 176 
spliced and amplified with primers splA1 and splA4, giving an amplicon of 4,818 bp which was digested 177 
with BsaI and StuI and ligated to restricted, dephosphorylated plasmid pnso to produce plasmid pnsoΔnsoA, 178 
which was transformed into L. lactis MG1614. Both pnso and pnsoΔnsoA were also transformed into L. 179 
lactis UKLc10. 180 
The nsoA genes were cloned separately into a nisin-inducible expression vector. Each nsoA gene was 181 
amplified using primer combinations pTGA13 with a13AleI for gene nsoA1 and pTGA23 with a13AleI for 182 
gene nsoA2 and pTGA23 with a43AleI for genes nsoA3-nsoA4 to make amplicons nsoA1Ale, nsoA2Ale and 183 
nsoA3nsoA4Ale respectively. The region of plasmid pFI2596 (Fernandez et al., 2009) containing the nisin 184 
promoter PnisA was amplified using primers pTG262-F with a15pTG to make amplicon nisPa and pTG262-F 185 
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with a25pTG to make amplicon nisPb. The PnisA and nsoA amplicons were used as DNA templates in splice 186 
overlap extension PCR by combining templates nisPa with nsoA1Ale using primers pTG262-F with a13AleI, 187 
nisPb with nsoA2Ale using primers pTG262-F and a13AleI and finally nisPb with nsoA3nsoA4Ale using 188 
primers pTG262-F and a43AleI. The PnisA-IL12 region of pFI2596 was then replaced with the spliced 189 
amplicons containing the nsoA genes by SmaI and AleI digestion and ligation to digested, dephosphorylated 190 
plasmid pFI2596. Ligation products were transformed into L. lactis MG1614. Clones with PnisA-nsoA1 191 
(pTGnsoA1), PnisA-nsoA2 (pTGnsoA2) and PnisA-nsoA3-nsoA4 (pTGnsoA3-nsoA4) were identified as 192 
described previously using primers p54 and p181 and transformed into electrocompetent MG1614-pnso, 193 
MG1614-pnsoΔnsoA, UKLc10-pnso and UKLc10-pnsoΔnsoA. The nisA gene was also subcloned into 194 
pTG262 as a positive control; nisA was amplified from L. lactis FI5876 genomic DNA by PCR using 195 
primers NisA-BspHF and NisA-BspHR, restricted with BspHI and ligated into NcoI-restricted pUK200. 196 
After transformation into E. coli MC1022 and sequence confirmation the insert was then excised with SspI 197 
and EcoRI and cloned into HindIII-EcoRI restricted pTG262. 198 
 199 
Cloning of hybrid nisAL -nsoA genes into the nisin A biosynthetic system.  Hybrid nisAL-nsoA pre-200 
peptides were designed to contain the full NisA leader sequence MSTKDFNLDLVSVSKKDSGASPR 201 
(nisAL) followed by the predicted NsoA structural peptides of nsoA1 with possible cleavage sites: nsoA1IE:  202 
IEPKYKSKSACTPGCPTGILMTCPLKTATCGCHITGK, nsoA1YK: 203 
YKSKSACTPGCPTGILMTCPLKTATCGCHITGK or nsoA4: 204 
ITSQHSFCTPNCLTGFLCPPKTQLTCTCKLKGQ. The 69 bp nisAL DNA was amplified from L. lactis 205 
FI5876 genomic DNA using primer pr1 combined with each primer 1pr2ie, 1pr2yk or 4pr2 to make nisALIE, 206 
nisALYK and nisAL4 amplicons respectively and the nsoA1 and nsoA4 structural genes were amplified from 207 
plasmid DNA containing the full lantibiotic cluster using primer 1Pr4 combined with 1Pr3IE, 1Pr3YK or 208 
4Pr3 to make amplicons nsoA1IE, nsoA1YK and nsoA4 respectively. Each hybrid nisAL-nsoA was prepared 209 
by splice overlap extension PCR using template sets nisALIE with nsoA1IE and nisALYK with nsoA1YK with 210 
primers pr1 and lanA14 to make nisAL-nsoA1IE and nisAL-nsoA1YK respectively and templates nisAL4 with 211 
nsoA4 with primers pr1 and LanA44 to make nisAL-nsoA4. Purified PCR products were digested with BspHI 212 
and XbaI and ligated into NcoI and XbaI restricted, dephosphorylated pUK200 and products transformed 213 
into electrocompetent E. coli MC1022. After sequence confirmation using primers p54 and p181, plasmid 214 
DNA from positive clones and the pUK200 vector control was transformed into L. lactis strains 215 
FI5876ΔnisA, FI5876ΔnisP, FI5876ΔnisB, FI5876ΔnisC and FI5876ΔnisCP. 216 
 217 
Construction of nsoI and nisI expression vectors.  The nsoI gene was amplified from pnso using primers 218 
pTGI3 with iAleIb and the nisin promoter region of plasmid pFI2596 was amplified with primers i5pTG and 219 
pTG262-F. Splice overlap extension PCR was performed using pTG262-F with iAleIb, the product was 220 
ligated into SmaI and AleI digested, dephosphorylated pFI2596 and transformed into L. lactis MG1614. 221 
Inserts were confirmed by sequencing using primers pTG262-F and pTG262-R. The nisI gene was amplified 222 
from L. lactis FI5876 genomic DNA using primers spI5 and splI3AleI and the nisin promoter region of 223 
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plasmid pFI2596 was prepared using primers splA1 and pTG262-F. These two amplicons were spliced and 224 
amplified using pTG262-F with iAleIb and ligated into vector pFI2596 as described for nsoI.  225 
 226 
Measurement of bacterial growth, viability and phenotype.  L. lactis FI5876ΔnisA pnisAL-nsoA1YK, L. 227 
lactis FI5876ΔnisA pUK200 and L. lactis FI5876ΔnisP pnisAL-nsoA1YK were subcultured from overnight 228 
cultures in selective media and at 2 h were induced with 10 ng/ml nisin A. After 18 h growth the cultured 229 
cells were prepared for scanning and transmission electron microscopy (SEM and TEM) analysis as 230 
described previously (Dertli et al., 2013; Pitino et al., 2012). Samples were examined and imaged in a FEI 231 
Tecnai G2 20 Twin transmission electron microscope at 200 kV. Bacterial growth was measured using a 232 
Labsystems Bioscreen C (Labsystems Oy). Test cultures were subcultured twice from glycerol stocks and 233 
induced appropriately overnight for 16 h. Cells were pelleted by centrifugation (10,000 g, 10 min), 234 
resuspended in 1 ml PBS, pelleted again and resuspended to an optical density (OD600) of 3.0 in selective 235 
media. Bioscreen plates (honeycomb, Thermo Fisher Scientific) were prepared with 300 μl media per well 236 
seeded with 1% of the prepared inoculum in triplicate and grown at 30˚C. To measure viability, stationary 237 
phase L. lactis strains were washed and resuspended in PBS then diluted 500-fold in filter sterilized PBS 238 
with 1 μl each of propidium iodide and FM 4-64FX (Life Technologies) then analyzed on a Cytomics FC500 239 
MPL (Beckman Coulter). Flow cytometry data were analysed using Flowjo (Treestar). 240 
 241 
Preparation and analysis of protein extracts.  Pre-warmed media was inoculated with 1:100 v/v overnight 242 
culture of L. lactis strains expressing hybrid plasmids. At mid exponential phase cultures were induced with 243 
10 ng/ml nisin and incubated from 2 h to overnight. Cells were harvested by centrifugation (4000 g, 40 min, 244 
4˚C) and frozen while total protein from filtered (0.45 μm) culture supernatants was precipitated by adding 1 245 
g/ml (nisin leader hybrids) or 20% (nsoA pre-peptides) cold trichloroacetic acid (TCA) and incubating 246 
overnight at 4˚C. Precipitated proteins were pelleted by centrifugation (13000 g, 30 min, 4˚C), washed with 247 
ice cold acetone and resuspended in 0.05 volumes 50 mM sodium acetate (pH 5.5). Cells were resuspended 248 
in 50 mM sodium acetate (pH 5.5) (MG1614) or 0.2 M Tris HCl pH 7.4 (UKLc10) and soluble protein 249 
extracts produced by bead beating (Mayer et al., 2008). Proteins were analysed by SDS-PAGE 250 
electrophoresis and Western blotting as described previously (Mayer et al., 2008) using 12% or 4-12% Bis-251 
Tris NuPAGE gels in MES SDS buffer (Invitrogen) and an antibody (at 1/100 dilution) raised against the 252 
nisin A leader peptide or a polyclonal anti-leader peptide antibody raised by Genscript Corp (NJ, USA) from 253 
synthesized N-terminal acetylated NsoA1 leader peptide H2N-AKFDDFDLDVTKTAAQGGC-CONH2 with 254 
anti-Rabbit IgG-alkaline phosphatase secondary antibody (Sigma).  255 
 256 
Antimicrobial activity and testing of different media and inducing agents.  To measure antimicrobial 257 
activity using drop tests, strains were cultured from glycerol stocks in the appropriate media overnight and 258 
subcultured twice before inoculating the appropriate media. For overlay assays, B. obeum A2-162 was sub-259 
cultured twice in liquid media before plating or streaking on solid media or solid media supplemented with 260 
50 μg/ml trypsin. After 1 to 7 d incubation cultures were killed using chloroform treatment, overlaid with 261 
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soft media (0.7 % w/v agar) seeded with indicator bacteria and incubated overnight. For heterologous 262 
production, L. lactis strains were sub-cultured with 10 ng/ml nisin A then 5 µl overnight culture spotted on 263 
solid agar with 20 mg/l NaHCO3 and 10 ng/ml nisin and grown overnight. Bacterial growth was killed by 264 
irradiation with UV light for 15 min then overlaid with soft medium containing 1-2% of an overnight culture 265 
of the indicator strain, with or without trypsin (sequencing grade modified trypsin, Promega, 1 or 5 µg/ml or 266 
trypsin Tpck treated from bovine pancreas Sigma at 1, 5, 10 or 15 µg/ml). Plates were incubated overnight in 267 
the conditions preferred by the indicator strain. 268 
To attempt to induce antimicrobial production, B. obeum A2-162 and L. lactis MG1614 and FI5876 were 269 
cultured from glycerol stocks in selective media overnight then subcultured in a range of test media (BHI pH 270 
5.0, 6.0 and 7.0, BHI with 5 mg/l hemin, YCFA medium, PYGS medium, de Man Rogosa Sharp medium, 271 
Reinforced Clostridial Medium, Luria broth, lysogeny broth, Rogosa, GM17, M17 supplemented with 5% of 272 
each: lactose, mannitol, cellobiose, mannose, sorbitol, galactose, xylose or inulin, all with and without 50 273 
μg/ml trypsin) and inducing agents. Inducing agents included 5 g/l yeast extract, a mixture of 2 g/l glucose, 1 274 
g/l soluble starch, 2 g/l cellobiose, a mixture of 2 g/l xylose, cellobiose and sorbitol, 2 g/l inulin, 2 g/l sodium 275 
acetate 3-hydrate, 0.31% volatile fatty acids mix (33 mM acetic acid, 9 mM propionic acid, 1 mM n-valeric 276 
acid, 1 mM isovaleric acid and 1 mM isobutyric acid), 50 μg/ml trypsin, heat killed C. perfringens culture, 277 
10 to 1000 ng/ml nisin A and combined trypsin and nisin. Filtered (0.22 μm) stationary phase culture 278 
supernatants from L. lactis strains MG1614-pnso, MG1614-pIL253 or FI5876 with and without nisin (1:20 279 
v/v) and L. lactis cell extracts in 50 mM NaOAc or 50 mM NaOAc, 8 M Urea buffer and supernatant TCA-280 
extracted proteins were also tested as inducers of activity in B. obeum A2-162; and spent culture of B. obeum 281 
was similarly tested as an additive to nisin-induced MG1614-pnso culture. Samples were tested for 282 
antimicrobial activity using well diffusion, drop tests and overlay assays (Ryan et al., 1996).  283 
To remove leader peptides, soluble cell extracts (2 μg) and TCA precipitated culture supernatant extracts 284 
from B. obeum A2-162 and L. lactis strains were digested with 0.5 mg/ml trypsin for 1 h at 37˚C in 50 mM 285 
sodium acetate buffer (pH 5.5) (Cheng et al., 2007), or subcultured to media containing 2.5 μg/ml nisin A 286 
and 1:40 v/v filter sterilized culture supernatant of Bacillus subtilis. Samples were assayed for antimicrobial 287 
activity using well diffusion assays. Additionally, L. lactis MG1614-pnso and its derivative strains were 288 
cultured with 100 ng/ml of inducing nisin A and cross-streaked with B. subtilis, grown overnight then 289 
overlaid with C. perfringens. 290 
 291 
RESULTS 292 
B. obeum A2-162 contains a lantibiotic-like gene cluster 293 
Previous studies have shown novel lantibiotic genes can be identified by PCR using degenerate primers 294 
designed from conserved regions of lantibiotic cluster genes (Mayer et al., 2006; Wirawan et al., 2006). 295 
Here, AT-rich degenerate primers were designed and used to screen a bacterium previously isolated from the 296 
human GI tract for lanC-like sequences. We identified a 180 bp DNA sequence from B. obeum A2-162, 297 
whose translated product aligned with other LanC proteins. The sequence was extended in both directions 298 
and a full lanC-like gene as well as part of a lanT-like gene indicated that the genes belonged to a lantibiotic 299 
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cluster. A DNA library in the E. coli linear vector pJAZZ-OC was prepared and the surrounding genes were 300 
sequenced in both directions by primer walking, identifying a c. 15 kb lantibiotic cluster within a c. 19 kb 301 
insert. Comparison to clusters of other nisins and subtilin suggested that the full cluster had been identified. 302 
Later publication of the whole draft genome (GenBank FP929054, A. Pajon, K. Turner, J. Parkhill, S. 303 
Duncan and H.,Flint, 2015, unpublished) confirmed this. 304 
Computational analysis of the cluster identified 15 probable ORFs encoding lantibiotic–associated genes 305 
(abbreviated with nso here), whose functions were predicted by BLASTp analysis (Figure 1a, Table S2). The 306 
genes all had the same orientation and included four nsoA genes, with the first three coding for identical 307 
proteins with only one amino acid difference in the leader peptide (Figure 1b), nsoB and nsoC biosynthetic 308 
genes, an nsoT ABC transporter, two sets of nsoRK two-component regulator system genes and nsoI and 309 
nsoFEG genes presumed to be involved in immunity. No probable protease genes capable of cleaving the 310 
leader sequence were identified; the predicted NsoT protein showed similarity to other NisT type lantibiotic 311 
ABC transporter ATP-binding proteins and did not contain the N-terminal protease domain responsible for 312 
leader cleavage in dual-function ABC transporters which is frequently found in lantibiotic clusters which do 313 
not contain a lanP gene. A 506 bp region between the end of nsoK1 and the start of nsoA1 genes displayed 314 
no homologies to other known genes commonly found in lantibiotic clusters.  315 
The predicted mature protein sequence of nsoA1 was found to be very similar to other NisA proteins, with 316 
conservation of the positions of the serine, threonine and cysteine residues; the predicted mature protein 317 
sequence of nsoA4 showed a lower similarity but had the majority of serine, threonine and cysteine residues 318 
in similar positions to other nisin analogues (Figure 1b). The spaces separating the nsoA genes were 22, 23 319 
and 19 bp with the first two gaps exhibiting 95% identity. BLASTp searches categorized the three NsoA1-3 320 
pre-peptides as part of the gallidermin/nisin family with 63% identity to the nisin U precursor peptide. The 321 
N-terminal region of the NsoA1-3 pre-peptides contained an FDLD motif followed by a GG motif and a 322 
further PK motif. The most likely leader peptide cleavage sites were therefore presumed to be following 323 
either the GG or the PK motif and the two predicted structural peptides are referred to as NsoA1IE and 324 
NsoA1YK respectively. These exhibited 82% and 90% sequence identity to nisin U respectively (Figure 1b). 325 
Only an FDLD leader peptide motif was identified in the N-terminal region of the NsoA4 pre-peptide and an 326 
ITS amino acid sequence resembling that of the start of the active nisin A was found in a similar region of 327 
the pre-peptide. The predicted NsoA4 structural peptide is one amino acid shorter than nisin A and showed 328 
the best similarity to geobacillin I (59% identity).  329 
BLASTp analysis of an ORF at the 5’ end of the cluster (orf1) showed homology to the second half of a 330 
transcriptional regulator from B. obeum (Figure 1a, Table S2); the preceding nucleotide sequence encoded 331 
the earlier part of the protein but contained frame shifts. At the 3’ end of the cluster, orf2 showed homology 332 
to hypothetical proteins from several Clostridiales species and to a transposase from an uncultured faecal 333 
bacterium (AMP50088, 2e-52). This was followed by sequences which matched short regions of database 334 
proteins with the sequence interrupted by frameshifts – orf3 and orf4 had similarity to consecutive regions 335 
from a transposase from Blautia wexlerae and to other transposases from a range of other Clostridiales 336 
bacteria, while orf5 and orf6 matched consecutive regions of a putative transcriptional regulator. The first 337 
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seemingly complete protein is orf7, which shows high homologies to DNA binding response regulators; orf8 338 
is truncated by the end of the clone and has similarity to ATP binding proteins/sensory histidine kinases.  339 
 340 
The nisin O cluster may have evolved from the nisin U cluster 341 
BLASTn comparison of the full nisin O cluster to those of the other nisins did not show considerable 342 
sequence conservation, but tBLASTx showed a high similarity between the nisin O cluster and nisins U, A 343 
and Q (Figure 1c). It was interesting to note that the GC percentage of the three highly similar nsoA genes 344 
was higher than that of the fourth structural gene and the rest of the cluster, whose average GC content was 345 
31% in comparison to 41.6% for the producing organism B. obeum A2-162. 346 
Comparison of all nisin and B. obeum A2-162 clusters showed the clusters of nisins Q and A were highly 347 
conserved, while there appeared to be an inversion event between the nisin A and nisin U clusters which was 348 
also present in the nisin O cluster. The 3’ end of the nisin U cluster containing nsuA, nsuB, nsuT and nsuC 349 
was conserved in the nisin O cluster while the 5’ end of the cluster containing genes nsuP, nsuRK and 350 
nsuFEG showed evidence of a few translocations of genes between the clusters. BLASTn search of the 351 
region between nsuA and nsuG in the nisin U cluster showed the presence of a ISSmu4-like putative 352 
transposase sequence (DQ368682) within the region. However, BLASTp analysis shows that the Nso 353 
translated proteins share the best homologies with proteins from other Clostridiales and Bacillales bacteria, 354 
frequently from faecal sources, so any evolution from Streptococcus uberis would appear to be ancient. 355 
 356 
B. obeum A2-162 exhibits trypsin-induced antimicrobial production on solid media 357 
A range of growth conditions, culture media and media additives which included supernatants or cell extracts 358 
from spent cultures were tested for their ability to induce antimicrobial production in B. obeum A2-162. 359 
From those, only cultures grown for at least 4 days in liquid culture then plated on solid media supplemented 360 
with 50 μg/ml trypsin before overlaying reproducibly showed evidence of antimicrobial production against 361 
the indicator strain C. perfringens (Figure 2); no antimicrobial activity was detectable from culture 362 
supernatants by drop tests. 363 
 364 
Hybrid NisAL-NsoA peptides alter the phenotype of L. lactis when they are expressed in the presence 365 
of the nisin modification machinery 366 
To investigate whether the nisin A biosynthetic cluster could modify and produce active NsoA peptides, the 367 
predicted leader of each NsoA pre-peptide was replaced with that of nisin A (nisAL) and the hybrid nisAL-368 
nsoA1IE, nisAL-nsoA1YK and nisAL-nsoA4 genes were expressed from vector pUK200 in L. lactis strains 369 
FI5876ΔnisA, FI5876ΔnisP, FI5876ΔnisB, FI5876ΔnisC and FI5876ΔnisCP. 370 
Although plasmids expressing nisAL-nsoA1IE and nisAL-nsoA4 had no effect on growth, strain FI5876ΔnisA 371 
pnisAL-nsoA1YK exhibited a longer lag phase and reached lower maximum OD600 values (Figure 3a). This 372 
strain displayed an aggregated phenotype in liquid culture, and TEM and SEM revealed loss of cell shape, 373 
extensive aggregation and less defined cell membranes (Figure 3b), suggesting problems with membrane 374 
synthesis or stability. The nisin biosynthetic gene knockout strains FI5876ΔnisB, FI5876ΔnisC and 375 
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FI5876ΔnisP containing the hybrid plasmid pnisAL-nsoA1YK were not phenotypically different from their 376 
empty vector control counterparts and showed similar growth rates, suggesting that the nisin biosynthetic 377 
genes were necessary for the slow growth phenotype (Figure 3c). These results were supported by flow 378 
cytometry analysis of stationary phase cells, showing that FI5876ΔnisA pnisAL-nsoA1YK had an increased 379 
percentage of PI-positive cells (Figure 3d).  380 
Despite the altered growth and phenotype, strains expressing pnisAL-nsoA hybrids showed no evidence of 381 
antimicrobial activity using a number of different antimicrobial detection tests, which included the use of 382 
trypsin or filtered culture supernatant as inducers (data not shown). However, using an antibody to the nisin 383 
A leader, Western analysis of FI5876ΔnisA containing pnisAL-nsoA1IE, pnisAL-nsoA1YK, pnisAL-nsoA4 or 384 
pUK200 identified a band at c. 6 kDa only in the FI5876ΔnisA pnisAL-nsoA1YK samples (Figure 4a). The 385 
absence of this band in the other strains suggests that NisAL-NsoA1IE or NisAL-NsoA4 are either not 386 
produced or not modified, causing instability and rapid degradation of produced pre-peptides. Examination 387 
of nisin biosynthetic gene knockout strains demonstrated that deletions in nisB, nisC or nisCP prevented 388 
accumulation of the NisAL-NsoA1YK pre-peptide (Figure 4b). Western analysis did not detect any cleaved 389 
nisin A leader, but it did show the presence of the prepeptide in TCA-precipitated culture supernatants 390 
(Figure 4a), suggesting that the prepeptide was either exported or released from damaged or lysed cells 391 
during culture. 392 
 393 
NsoA production in the presence of nisin O biosynthetic machinery in L. lactis 394 
We inserted a 17,438 bp sequence containing the lantibiotic cluster into pIL253 to create plasmid pnso and 395 
transformed it into the non-nisin producer L. lactis MG1614. Initial antimicrobial testing of this strain using 396 
deferred antagonism tests did not identify any antimicrobial activity. However, a high level of resistance to 397 
nisin A was observed in both MG1614-pnso and in a strain where the four nsoA genes had been deleted 398 
(MG1614-pnsoΔnsoA) (Figure 5a). The putative nsoI gene and the nisin immunity gene nisI were expressed 399 
in MG1614 separately; although pTGnisI increased the immunity of MG1614 to nisin A, pTGnsoI did not 400 
(data not shown). Nisin A was detrimental to B. obeum A2-162 at concentrations above 100 ng/ml, 401 
suggesting that the immunity systems conferring resistance to the MG1614-pnso strain were not being 402 
expressed.  403 
We hypothesised that functional similarities between nisin O and nisin A clusters might allow one of the 404 
nsoRK systems to interact with nisin A to induce expression via the nisin A promoter. Genes nsoA1, nsoA2 405 
and nsoA3-nsoA4 were inserted into vector pTG262Pn under the control of the nisin A promoter and co-406 
expressed in MG1614-pnso and MG1614-pnsoΔnsoA with nisin A induction. Western blot analysis with a 407 
peptide antibody made to the NsoA1 leader showed hybridisation at c. 6 kDa to the MG1614-pnso 408 
pTGnsoA3-nsoA4 samples (Figure 6). There was also faint hybridisation to extracts from MG1614-pnso 409 
containing pTG262Pn. The 6 kDa band was not detectable in any of the strains expressing just the A1 or A2 410 
sequences, MG1614-pnsoΔnsoA samples, the original producer B. obeum A2-162 or nisin producer FI5876. 411 
It was not possible to identify a cleaved leader at c. 2 kDa (cleaving at GG/IE) or c. 2.5 kDa (cleaving at PK) 412 
in these cell extracts, possibly due to high background hybridisation in this size range or instability of the 413 
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cleaved leader peptide. None of these cell extracts produced antimicrobial activity. Attempts to cleave the 414 
leader peptide and release an active antimicrobial from these strains using treatment of culture supernatants 415 
with trypsin, or culture supernatant from B. subtilis, which is known to produce extracellular proteases, or by 416 
co-culturing with B. subtilis, failed to produce an antimicrobial activity against C. perfringens (data not 417 
shown).  418 
 419 
Antimicrobial activity after nisin A induction and trypsin treatment 420 
To investigate whether nisin A could act as a heterologous inducer of the nso pre-peptides, pnso or 421 
pnsoΔnsoA were expressed in L. lactis UKLc10, which has the nisRK genes integrated in the chromosome, 422 
and cultures were induced with 10 ng/ul nisin. Western analysis showed improved production of the pre-423 
peptide in both cell extracts and TCA-precipitated supernatants from cultures after nisin induction (Figure 7). 424 
Culture supernatants from these strains did not exhibit antimicrobial activity. However, when strains were 425 
grown on solid media containing nisin A and then overlaid with indicator strains in soft agar containing 426 
trypsin, clear activity was seen against C. perfringens, C. difficile and L. lactis (Figure 8). These zones of 427 
inhibition were absent when trypsin was not added to the soft agar but were evident in the presence of 1, 5, 428 
10 and 15 ng/ul trypsin from either source. The activity seen from the positive nisin A control strain 429 
FI5876ΔnisA pTGnisA was maintained in the presence of trypsin. 430 
 431 
DISCUSSION 432 
In this work a novel Type A lantibiotic cluster with a unique gene arrangement was discovered in the 433 
genome of B. obeum A2-162 and heterologous production of the structural peptides in L. lactis was 434 
investigated using either the native or the nisin A biosynthetic machinery. According to Sahl et al. (Sahl et 435 
al., 1995), lantibiotic natural variants can be defined as having only a few amino acid substitutions, 436 
essentially the same ring pattern, and cross immunity between producing strains. The novel cluster contained 437 
a triplicate structural peptide which showed close sequence similarity to other nisins and conservation of the 438 
predicted ring positions, while the lantibiotic cluster provided immunity to exogenous nisin A. Consequently, 439 
the predicted lantibiotic was regarded as a member of the nisin group and named nisin O. However, it was 440 
interesting to note that the native producer B. obeum showed sensitivity to nisin A, suggesting that the 441 
immunity system may require induction. O’Connor et al. (O'Connor et al., 2015) also found that the native 442 
nisin U producing strain S. uberis was inhibited by supernatant from a nisin A producer.  443 
The nisin O cluster is unusual in that it is the first nisin cluster to have more than one copy of a nisin-like 444 
structural gene, two sets of lanRK genes and no identifiable protease. Differences in nisin cluster gene 445 
arrangements have been described before (O'Connor et al., 2015; Richards et al., 2011; Wirawan et al., 446 
2006) and have been proposed to be a consequence of horizontal gene transfer, but up to now only nisin H 447 
has been found to be different in its gene content with the absence of a detectable nisI (O'Connor et al., 448 
2015). At the pre-peptide level, the nsoA genes deviated from the conserved leader peptide and cleavage 449 
sequences found in other nisA genes. Class I lantibiotic leader peptides share conserved F(N/D)LD boxes 450 
and C-terminal PQ or PR amino acid sequences while Class II lantibiotic leader peptides contain the motif 451 
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ELXXBXG (B= V,L or I) and usually end in a GG motif (Plat et al., 2011); only the F(N/D)LD box was 452 
present in all the NsoA leader peptides.  453 
This is also the first report of a nisin-like cluster in the genus Blautia. B. obeum-like organisms can make up 454 
a significant percentage of the faecal microbiome (Lawson and Finegold, 2015). Increased levels of Blautia 455 
in the human gut have been associated with a reduced risk of death from graft-versus-host disease (Jenq et 456 
al., 2015), as well as good cognition and reduced inflammation (Bajaj et al., 2012), while decreased levels 457 
have been associated with the occurrence of type I diabetes in children (Murri et al., 2013) and increased risk 458 
of colorectal cancer (Chen et al., 2012). The amount of influence and mechanisms which lie behind the 459 
associations of intestinal Blautia to these conditions, and whether lantibiotic production is important to their 460 
ecology, is currently unknown.  461 
The nisins discovered to date are produced by L. lactis (A, Z, F, Q), Streptococcus uberis (U), Streptococcus 462 
agalactiae (U2), Streptococcus gallolyticus and Streptococcus suis (P) and more recently another gut-derived 463 
strain, Streptococcus hyointestinales (H) (O'Connor et al., 2015). An in silico study of the genomes of gut 464 
bacteria from the Human Microbiome Project identified lantibiotic-associated genes from a range of genera, 465 
including R. obeum A2-162 (Walsh et al., 2015). Other Clostridiales have been shown to produce the 466 
bacteriocins albusin B, a type III bacteriocin (Chen et al., 2004) and the lantibiotics ruminococcin A and 467 
ruminococcin C (Crost et al., 2011; Dabard et al., 2001), but these were not found to have any sequence 468 
similarities to the nisin O cluster. The discrepancy between the GC content of the structural gene region, the 469 
remaining cluster and the producer organism and the presence of transposase-like sequences at the 3’ end of 470 
the cluster could signify that some ORFs have been acquired by horizontal gene transfer. The high gene and 471 
intergenic sequence similarity between the nsoA1 genes suggests that the triplication occurred by consecutive 472 
duplication events. This is not unprecedented - ruminococcin A, also found in the gut and induced by trypsin, 473 
contains three rumA genes in its cluster which code for the same peptide (Marcille et al., 2002). Two-474 
component lantibiotics which contain two active structural genes are not uncommon (Lawton et al., 2007). 475 
McAuliffe et al. (2000) observed that in most cases the sequence of two pre-peptides in two-component 476 
lantibiotics is c. 25% conserved, while many contain different enzymes for post-translational modification of 477 
each peptide. It is not known whether nsoA4 encodes a functional lantibiotic peptide which is active on its 478 
own or in combination with nsoA123 peptides - further work in heterologous systems or the original host is 479 
required to determine its contribution. 480 
Several lantibiotics have been successfully produced using the nisin A biosynthetic machinery 481 
(Majchrzykiewicz et al., 2010; Piper et al., 2011). Slow growth, an altered phenotype and reduced viability 482 
effects in nisin leader hybrid expressing strains suggest that the NsoA1YK peptide can be stably expressed, 483 
but this is detrimental to L. lactis in the presence of the nisin biosynthetic machinery. These effects, 484 
combined with the visualisation of hybrid pre-peptides, suggest that the YK site is the correct start of the 485 
mature NsoA1. However, despite extensive experimentation using extracts from B. obeum A2-162 and 486 
hybrid NisAL-NsoA producing strains, we did not identify any inducing agents able to produce antimicrobial 487 
activity in liquid culture. This suggests that the prepeptides are produced but not cleaved to the active 488 
product. As with subtilin (Corvey et al., 2003; Stein and Entian, 2002) and mutacin I (Qi et al., 2001), an 489 
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extracellular protease encoded elsewhere in the genome might be necessary for cleavage of the NsoA leader 490 
peptides to activate the B. obeum A2-162 lantibiotics, and under the culture conditions used this protease was 491 
either not expressed from the native strain or was not effective. The differences in the NsoA leader peptides 492 
and starts of the active peptides compared to other nisin analogues support the hypothesis that processing 493 
uses a different type of protease. Experiments using trypsin, filter sterilized B. subtilis spent culture 494 
supernatants or co-culturing with B. subtilis strains before overlaying with C. perfringens did not show 495 
reliable evidence of antimicrobial activity. However, antimicrobial activity against C. perfringens was 496 
observed when B. obeum A2-16 was cultured on solid media with trypsin. Lantibiotic regulation by trypsin 497 
has been seen before with ruminococcin A, a response that suggests adaption to its environment in the gut 498 
(Gomez et al., 2002). Given the presence of two nsoRK systems and the low antimicrobial production it 499 
could be that a further inducing factor is involved in regulation in the native host. This factor and/or the 500 
antimicrobial itself may be expressed in low quantities by B. obeum A2-162 and could be concentrated 501 
around the culture in solid media but would be too dilute in liquid media, explaining our inability to detect 502 
antimicrobial activity from culture supernatants. The yield of nisin H in culture supernatants from gut 503 
bacterium S. hyointestinalis was also found to be low compared to that of nisin A (O'Connor et al., 2015). 504 
Production of mutacin I, the Bifidobacterium longum DJO10A lantibiotic and the two component 505 
haloduracin from Bacillus halodurans were also only seen on solid media (Lee et al., 2011; McClerren et al., 506 
2006; Qi et al., 2001) and it has been proposed that the dense colonization necessary for mutacin I 507 
production is reminiscent of a biofilm condition (Qi et al., 2001). Alternatively, the mechanism of trypsin 508 
may rely on pre-peptide cleavage rather than induction; in vitro biosynthesis of nisin using just nisABC 509 
successfully produced active nisin after treatment with trypsin (Cheng et al., 2007). Trypsin is known to 510 
cleave after arginine or lysine residues and there is a lysine immediately before the proposed NsoA1,2,3 YK 511 
peptides, so trypsin activity could be generating the mature peptide in the absence of a suitable host protease, 512 
as appeared to be the case where trypsin was included in the soft agar of overlay assays of the nso cluster in 513 
L. lactis. In either case, trypsin could be a useful tool to identify novel lantibiotic activity from gut bacteria. 514 
The nso cluster was able to confer immunity to nisin A in L. lactis MG1614-pnso, and the use of nisin A to 515 
induce coexpression of nsoA genes allowed visualisation of bands which hybridized to the NsoA1 leader 516 
antibody. As nisin variants have been shown to induce the production of alternative nisin genes (Wirawan et 517 
al., 2006), we investigated whether nisin A was able to induce nso gene expression using a strain with the 518 
NisRK two-component regulatory system integrated into the chromosome. This increased production to 519 
levels high enough to identify antimicrobial activity, as long as trypsin was present in the overlaying agar, 520 
presumably to release the active peptide from the leader sequence. Given that the full peptide is expected to 521 
be only a small fraction of the peptides generated by trypsin digestion, the resultant activity is impressive and 522 
suggests that further understanding and production of this lantibiotic could provide a novel weapon against 523 
clostridial pathogens. Future production of mature peptides may allow us to test whether, like nisin A, the 524 
system is self-regulating and can be induced in the original host strain to produce the native modified 525 
peptide. 526 
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In this work screening of gut bacterial isolates for lantibiotic biosynthetic genes revealed a novel lantibiotic 527 
cluster from B. obeum with four novel structural peptides and an unusual leader peptide sequence. Cross-528 
immunity of the nisin O cluster to nisin A was demonstrated and heterologous expression of the novel cluster 529 
with the structural peptides on a nisin A inducible system showed evidence of antimicrobial activity against 530 
pathogens C. perfringens and C. difficile in the presence of trypsin. Further work on the regulation of this 531 
novel cluster and its spectrum of antimicrobial activity will expand our understanding of the evolution of 532 
type I lantibiotics and may lead to the development of novel antimicrobials to target gut pathogens.  533 
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 735 
Table 1. Strains and plasmids used in this study 736 
Strains Relevant characteristics Reference/ source 
L. lactis MG1614 L. lactis subsp. lactis 712 cured of plasmids and 
prophage 
(Gasson, 1984) 
L. lactis FI5876 MG1614 with the nisin A biosynthetic cluster (Dodd et al., 1990) 
L. lactis FI5876 ΔnisA Part of nisA deleted (FI7847) (Dodd et al., 1996) 
L. lactis FI5876 ΔnisP nisP deleted (FI8438) A. Narbad  
L. lactis FI5876 ΔnisC nisC deleted (FI8531) A. Narbad  
L. lactis FI5876 ΔnisCP nisC  and nisP deleted (FI8532) A. Narbad  
L. lactis FI5876 ΔnisB nisB deleted (FI8620) (Sen et al., 1999) 
L. lactis UKLc10 nisRK genes integrated on the chromosome (Wegmann et al., 1999) 
B. obeum A2-162 Genome mining strain isolated from human GI 
tract 
S. Duncan 
C. perfringens NCTC 
3110 
Indicator strain National Collection of Type 
Cultures 
C. difficile NCTC 11204 Indicator strain National Collection of Type 
Cultures 
E. coli MC1022 Shuttle vector cloning strain (Casadaban and Cohen, 1980) 
Plasmids     
pIL253 Erythromycin resistance (Simon and Chopin, 1988) 
pJAZZ-OC Chloramphenicol resistance (Lucigen Corp, USA) 
pUK200 Chloramphenicol resistance (Wegmann et al., 1999) 
pnisAL-nsoA4 pUK200 with the nisin leader peptide DNA 
sequence followed by the nsoA4 DNA 
sequence under the control of the nisA 
promoter 
This study 
pnisAL-nsoA1IE pUK200 with the nisin leader peptide DNA 
sequence followed by the nsoA1IE DNA 
sequence under the control of the nisA 
promoter 
This study 
pnisAL-nsoA1YK pUK200 with the nisin leader peptide DNA 
sequence followed by the nsoA1YK DNA 
This study 
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sequence under the control of the nisA 
promoter 
pnso nisin O lantibiotic cluster in pIL253 This study 
pnsoΔnsoA nisin O lantibiotic cluster in pIL253 with the 
nsoA genes deleted 
This study 
pFI2596 Nisin inducible vector based on pTG262 
engineered to contain the nisA promoter and 
RBS sequences followed by genes encoding the 
mIL-12 p40 and p35 subunits 
(Fernandez et al., 2009) 
pTG262Pn pFI2596 with mIL-12 removed, empty control 
vector 
This study 
pTGnsoA1 pTG262Pn with nsoA1 under the control of the 
nisA promoter 
This study 
pTGnsoA2 pTG262Pn with under the control of the nisA 
promoter 
This study 
pTGnsoA3-nsoA4 pTG262Pn with nsoA3 and nsoA4 under the 
control of the nisA promoter 
This study 
pTGnsoI pTG262Pn with nsoI under the control of the 
nisA promoter 
This study 
pTGnisI pTG262Pn with nisI under the control of the 
nisA promoter 
This study 
pTGnisA pTG262Pn with nisA under the control of the 
nisA promoter 
This study 
 737 
Figure legends 738 
Figure 1 (a) Organisation of the nisin O lantibiotic cluster and surrounding ORFs from the library clone; (b) 739 
Amino acid sequence alignment of the translated nsoA1, nsoA2, nsoA3 and nsoA4 genes to subtilin (SpaA, 740 
P10946), nisin Z (CAA79467), nisin U (ABA00878), nisin U2 (ADB43138), nisin F (ABU45463), nisin A 741 
(AAA25188), nisin Q (BAG71479), nisin P (BAK30164), and nisin H (AKB95119). Blue, mid blue, light 742 
blue and white correspond to conservation of 100%, 80%, 60% and <40% respectively; (c) Similarity of the 743 
nisin O lantibiotic cluster and with other lantibiotic clusters from nisin U (DQ146939), nisin A (HM219853), 744 
nisin Q (AB362350) and nisin H (KP793707); *, transposase or insertion element sequence.  745 
 746 
Figure 2 Antimicrobial activity. Overlay assays of B. obeum A2-162 after 6 d (top) or 7 d growth (bottom), 747 
grown on solid medium or solid media supplemented with 50 μg/ml trypsin and overlaid with C. perfringens.  748 
 749 
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Figure 3 Effect of hybrid genes on growth and phenotype. (a) Effect of hybrid constructs on the growth of L. 750 
lactis. X, FI5876, ●, FI5876ΔnisA pnisAL-nsoA1IE, ▲, FI5876ΔnisA pnisAL-nsoA1YK, ♦, FI5876ΔnisA 751 
pnisAL-nsoA4, □, FI5876ΔnisA pUK200. Results are the mean of triplicate measurements +/- SD. (b) SEM 752 
(left) and TEM (right) analysis of the effect of hybrid construct expression on cell phenotype; bar, 1 µm; (c) 753 
Growth of FI5876ΔnisA (▲), FI5876ΔnisP (●), FI5876ΔnisC (♦) and FI5876ΔnisB (■) containing pnisAL-754 
nsoA1YK (closed symbols) or pUK200 (open symbols); X, FI5876. (d) Viability of stationary phase L. lactis 755 
FI5876 and knockout strains containing pnisAL-nsoA1YK (red) or pUK200 (blue). 756 
 757 
Figure 4 Expression of nisin leader hybrids in L. lactis. SDS-PAGE electrophoresis (top) and Western 758 
hybridisation (bottom) using the nisin A leader antibody. (a) Extracts from cells (lanes 1, 2, 4, 5) and TCA-759 
precipitated culture supernatant (lane 3) from FI5876ΔnisA containing pnisAL-nsoA1IE (lane 1), pnisAL-760 
nsoA1YK (lanes 2, 3), pnisAL-nsoA4 (lane 4) or pUK200 (lane 5); (b) Extracts from cells (lanes 1-4, 8) and 761 
TCA-precipitated culture supernatant (lanes 5-7) from FI5876 biosynthetic gene knockout strains containing 762 
either pnisAL-nsoA1YK (lanes 1-7) or pUK200 (lane 8). Lanes 1 and 8, FI5876ΔnisA, lanes 2 and 5, 763 
FI5876ΔnisB, lanes 3 and 6, FI5876ΔnisC, lanes 4 and 7, FI5876ΔnisCP. M, marker. 764 
 765 
Figure 5 Effect of nisin O genes on immunity to nisin. Growth of L. lactis strains FI5876 (X), and MG1614 766 
with plasmids pIL253 (□), pnso (▲) or pnsoΔnsoA (●) in selective media supplemented with 1 μg/ml nisin 767 
A. Results are the mean of triplicate samples +/- SD  768 
 769 
Figure 6 Heterologous expression of the nso cluster. SDS-PAGE analysis (top) and Western hybridisation 770 
(bottom) using the NsoA1 leader antibody. Comparison of L. lactis TCA-precipitated culture supernatant 771 
extracts from MG1614-pnsoΔnsoA (lanes 1 to 5) or MG1614-pnso (lanes 6-10) containing plasmids 772 
pTG262Pn (1, 6), pTGnsoA1 (2, 7) pTGnsoA2 (3, 8), pTGnsoA3-nsoA4 (4, 5, 9, 10) and cell extracts from B. 773 
obeum A2-162 (11) and FI5876 (12); M, marker.  774 
 775 
Figure 7 Western hybridisation using the NsoA1 leader antibody to detect pre-peptide production in 776 
UKLc10. Comparison of L. lactis TCA-precipitated culture supernatant extracts (lanes 1-5) or cell extracts 777 
(lanes 6-11) from UKLc10 (lanes 1, 2, 4-8, 10, 11) or MG1614 (lanes 3,9) containing plasmids pnsoAΔA 778 
(lanes 1, 11), pnsoA (lanes 2, 6, 10), pnsoAΔA, pTGnsoA3-nsoA4 (lanes 3, 9), pIL253 (lanes 4, 8), pnsoA 779 
pTGnsoA3-nsoA4 (lanes 5, 7). Samples were induced with nisin for 3 h except lane 6 (2 h). M, marker. 780 
 781 
Figure 8 Antimicrobial activity in the presence of trypsin. Overlay assays of L. lactis strains grown on solid 782 
agar with NaHCO3 and 10 ng/ml nisin, then overlaid with soft agar with or without trypsin and the indicator 783 
strain.  784 
 785 
